← Browse by Condition
Medical Condition

rheumatoid arthritis ra

Total Trials
6
Recruiting Now
6
Trial Phases
Phase 2, Phase 4, Phase 1
NCT06991114 Phase 2
Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Enrollment
90 pts
Location
United States, Bulga...
Sponsor
Artiva Biotherapeutics, Inc.
View Trial →
NCT06913907 Phase 4
Recruiting

Changes in MTX-PG Concentrations During Subcutaneous MTX Therapy in Patients With Rheumatoid Arthritis(COSMOS Study)

Enrollment
100 pts
Location
Japan
Sponsor
Keio University
View Trial →
NCT06779123
Recruiting

Treatment With Auricular Vagus Nerve Stimulation in Rheumatoid Arthritis - the TRAVAGA Study

Enrollment
128 pts
Location
Sweden
Sponsor
taVNS AB
View Trial →
NCT07222696
Recruiting

Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being

Enrollment
250 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07182656 Phase 1
Recruiting

Safety, Tolerability, and PK/PD of CIGB-814 in Chinese Health Participants

Enrollment
70 pts
Location
China
Sponsor
Yi Fang
View Trial →
NCT06596772 Phase 3
Recruiting

A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04 [proposed Etanercept Biosimilar] to Enbrel® [EU-sourced] in Rheumatoid Arthritis

Enrollment
458 pts
Location
Bulgaria, Georgia, M...
Sponsor
mAbxience Research S.L.
View Trial →